117 related articles for article (PubMed ID: 15289013)
1. Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signaling.
Yamasaki S; Maeda M; Ohshima K; Kikuchi M; Otsuka T; Harada M
Leuk Res; 2004 Oct; 28(10):1023-31. PubMed ID: 15289013
[TBL] [Abstract][Full Text] [Related]
2. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression.
Armant M; Delespesse G; Sarfati M
Immunology; 1995 Jun; 85(2):331-7. PubMed ID: 7642225
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
4. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
Pillet AH; Thèze J; Rose T
Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells.
Zheng X; Wang Y; Wei H; Ling B; Sun R; Tian Z
Mol Immunol; 2008 May; 45(9):2559-69. PubMed ID: 18295891
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-18 in human natural killer cell is associated with interleukin-2.
Huang Y; Lei Y; Zhang H; Zhang M; Dayton A
Mol Immunol; 2010 Oct; 47(16):2604-10. PubMed ID: 21035858
[TBL] [Abstract][Full Text] [Related]
7. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
He YG; Mayhew E; Mellon J; Niederkorn JY
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 is expressed in human natural killer cells and is regulated by interleukin-2.
Jiang S; Munker R; Andreeff M
Nat Immun; 1996-1997; 15(6):312-7. PubMed ID: 9523282
[TBL] [Abstract][Full Text] [Related]
9. AKT plays a role in the survival of the tumor cells of extranodal NK/T-cell lymphoma, nasal type.
Chow C; Liu AY; Chan WS; Lei KI; Chan WY; Lo AW
Haematologica; 2005 Feb; 90(2):274-5. PubMed ID: 15710591
[TBL] [Abstract][Full Text] [Related]
10. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
[TBL] [Abstract][Full Text] [Related]
11. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
[TBL] [Abstract][Full Text] [Related]
14. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
15. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
16. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
[TBL] [Abstract][Full Text] [Related]
17. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells.
Ozdemir O; Savaşan S
Clin Immunol; 2005 Jun; 115(3):240-9. PubMed ID: 15893691
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-11 signaling is required for the differentiation of natural killer cells at the maternal-fetal interface.
Ain R; Trinh ML; Soares MJ
Dev Dyn; 2004 Dec; 231(4):700-8. PubMed ID: 15499555
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL.
Jiang W; Zhang J; Tian Z
Cytotherapy; 2008; 10(3):265-74. PubMed ID: 18418772
[TBL] [Abstract][Full Text] [Related]
20. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
